Your browser doesn't support javascript.
loading
Spinal cord injury causes chronic bone marrow failure.
Carpenter, Randall S; Marbourg, Jessica M; Brennan, Faith H; Mifflin, Katherine A; Hall, Jodie C E; Jiang, Roselyn R; Mo, Xiaokui M; Karunasiri, Malith; Burke, Matthew H; Dorrance, Adrienne M; Popovich, Phillip G.
Afiliación
  • Carpenter RS; Neuroscience Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Marbourg JM; Department of Neuroscience, The Ohio State University, Columbus, OH, USA.
  • Brennan FH; Belford Center for Spinal Cord Injury, The Ohio State University, Columbus, OH, USA.
  • Mifflin KA; Center for Brain and Spinal Cord Repair, The Ohio State University, Columbus, OH, USA.
  • Hall JCE; Neuroscience Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Jiang RR; Department of Neuroscience, The Ohio State University, Columbus, OH, USA.
  • Mo XM; Belford Center for Spinal Cord Injury, The Ohio State University, Columbus, OH, USA.
  • Karunasiri M; Center for Brain and Spinal Cord Repair, The Ohio State University, Columbus, OH, USA.
  • Burke MH; Department of Neuroscience, The Ohio State University, Columbus, OH, USA.
  • Dorrance AM; Belford Center for Spinal Cord Injury, The Ohio State University, Columbus, OH, USA.
  • Popovich PG; Center for Brain and Spinal Cord Repair, The Ohio State University, Columbus, OH, USA.
Nat Commun ; 11(1): 3702, 2020 07 24.
Article en En | MEDLINE | ID: mdl-32710081
Spinal cord injury (SCI) causes immune dysfunction, increasing the risk of infectious morbidity and mortality. Since bone marrow hematopoiesis is essential for proper immune function, we hypothesize that SCI disrupts bone marrow hematopoiesis. Indeed, SCI causes excessive proliferation of bone marrow hematopoietic stem and progenitor cells (HSPC), but these cells cannot leave the bone marrow, even after challenging the host with a potent inflammatory stimulus. Sequestration of HSPCs in bone marrow after SCI is linked to aberrant chemotactic signaling that can be reversed by post-injury injections of Plerixafor (AMD3100), a small molecule inhibitor of CXCR4. Even though Plerixafor liberates HSPCs and mature immune cells from bone marrow, competitive repopulation assays show that the intrinsic long-term functional capacity of HSPCs is still impaired in SCI mice. Together, our data suggest that SCI causes an acquired bone marrow failure syndrome that may contribute to chronic immune dysfunction.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Traumatismos de la Médula Espinal / Médula Ósea / Trastornos de Fallo de la Médula Ósea Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Traumatismos de la Médula Espinal / Médula Ósea / Trastornos de Fallo de la Médula Ósea Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos